• DRAMP ID

    • DRAMP29124
    • Peptide Name

    • Mastoparan-C [A5,8K]
    • Source

    • Synthetic construct
    • Family

    • Not found
    • Gene

    • N/A
    • Sequence

    • LNLKKLLKVAKKIL
    • Sequence Length

    • 14
    • Protein Existence

    • Protein level
    • Biological Activity

    • Antimicrobial, Antibacterial,Anti-Gram+, Anti-Gram-
    • Target Organism

      • [Ref.33285267]Gram-positive bacteria:Staphylococcus aureus ATCC 25923(MIC=16 µM); Bacillus subtilis ATCC 23857(MIC=4 µM);
      • Gram-negative bacteria:Escherichia coli ATCC 25922(MIC=8 µM); Pseudomonas aeruginosa ATCC 9027(MIC=4 µM); Klebsiella pneumoniae ATCC 700603(MIC=8 µM).
    • Hemolytic Activity

      • [Ref.33285267]15% hemolysis against mouse erythrocytes at 256 µM.
    • Cytotoxicity

    • No cytotoxicity information found in the reference(s) presented
    • Binding Target

    • liposomes
    • Linear/Cyclic

    • Linear
    • N-terminal Modification

    • Free
    • C-terminal Modification

    • Amidation
    • Nonterminal Modifications and Unusual Amino Acids

    • None
    • Stereochemistry

    • L
    • Structure

    • Alpha helix,random coil
    • Structure Description

    • The CD spectra in water adopts a random-coil conformation,3.56% α-helix was determined in 50% TFE.
    • Helical Wheel Diagram

    • DRAMP29124 helical wheel diagram
    • PDB ID

    • None
    • Predicted Structure

    • There is no predicted structure for DRAMP29124.
    • Formula

    • C78H148N20O16
    • Absent Amino Acids

    • CDEFGHMPQRSTWY
    • Common Amino Acids

    • KL
    • Mass

    • 1622.16
    • PI

    • 10.6
    • Basic Residues

    • 5
    • Acidic Residues

    • 0
    • Hydrophobic Residues

    • 8
    • Net Charge

    • +5
    • Boman Index

    • 98
    • Hydrophobicity

    • 0.464
    • Aliphatic Index

    • 195
    • Half Life

      • Mammalian:5.5 hour
      • Yeast:3 min
      • E.coli:2 min
    • Extinction Coefficient Cystines

    • 0
    • Absorbance 280nm

    • 0
    • Polar Residues

    • 1

DRAMP29124

    • Function

    • when combined with gentamicin, rifampin, and polymyxin B, it demonstrated synergistic or additive activity against E. coli ATCC 25922 and P. aeruginosa ATCC 9027.
  • ·Literature 1
    • Title

    • Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria.
    • Reference

    • Eur J Pharm Sci. 2021 Mar 1;158:105665.
    • Author

    • Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J.